Zaponex tablets are now available in an orodispersible formulation with strengths of 12.5mg, 25mg, 50mg, 100mg, 200mg. They are monitored via the Zaponex Treatment Access System just as their standard-release counterparts.
They are a suitable choice for patients who would prefer an oral dissolving formulation, or to improve outcomes in patients less compliant with standard-release tablets.
For more information speak to your ward pharmacist or call our Medicines Information hotline on 0843 506 5554.
Further information can also be found in the manufacturer’s information here.